Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib Retreatment in Advanced NSCLC (ReGaiN)
NCT00824746Phase 2Completed
- Sponsor
- Chonnam National University Hospital
- Start
- Jan 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Chonnam National University Hospital. Started Jan 2009; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00824746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00824746.